title: Benign intracranial hypertension associated with the withdrawal of a non-ergot dopamine agonist.
abstract: The cases are reported of two patients who developed benign intracranial hypertension after the withdrawal of the novel non-ergot derived dopamine agonist CV 205 502 (quinagolide).
authors.affiliation: Department of Endocrinology, Royal Liverpool Hospital, UK.
authors.forename: S L
authors.initials: SL
authors.lastname: Atkin
authors.forename: E A
authors.initials: EA
authors.lastname: Masson
authors.forename: L D
authors.initials: LD
authors.lastname: Blumhardt
authors.forename: M C
authors.initials: MC
authors.lastname: White
mesh_terms: D000328:Adult; D000634:Aminoquinolines / Q000009:adverse effects* / Q000494:pharmacology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D015259:Dopamine Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy; D008881:Migraine Disorders / Q000517:prevention & control; D011559:Pseudotumor Cerebri / Q000139:chemically induced*; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
chemical_list: D000634:Aminoquinolines; D015259:Dopamine Agents; C046650:quinagolide